Assessment of current approaches of starting dose selection and dose escalation for oncology biologics in first-in-patient trials.

e14093Background: Current approaches for starting dose selection for first-in-patient (FIP) trials of oncology biologics vary according to pharmacological properties and modality of the investigati...